-
Can Generative Artificial Intelligence (GenAI) Be Leveraged to Automate Scoping Searches of Systematic Literature Reviews (SLRs)?
Sep 9, 2025, 16:22 PM -
The Relevance of Core Outcome Sets to Improving Healthcare Decision Making
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of Similarities and Differences of RWE Standards Across Regulatory and Health Technology Assessment Bodies
Sep 9, 2025, 16:22 PM -
Pillcam COLON 2 for Investigation of the COLON Through Direct Visualization: A Systematic Review
Sep 9, 2025, 16:22 PM -
Natural Language Processing Solution (REALLI) to Evaluate the Limitations of the French National Health Insurance Database (SNDS): Example of HER2+ Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Association Between Nonvalvular Atrial Fibrillation Type and Therapeutic Failure in Hospitalized Patients With History of Atrial Fibrillation Admitted to a Stepdown Unit
Sep 9, 2025, 16:22 PM -
Rising Costs in Pharmaceutical Services: A Decade of Prescription Spending Trends in Türkiye 2015-2024
Sep 9, 2025, 16:22 PM -
Comparison of Bispecific T-cell Engager Antibodies and CAR-T Therapies for Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma: A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Out-of-Pocket Expenditures of Families Affected by Epidermolysis Bullosa in Europe
Sep 9, 2025, 16:22 PM -
Exploring Value in Healthcare: Patient Satisfaction in Spain Before and After the Pandemic
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization in Patients With Non-Small Cell Lung Cancer (NSCLC) and Epidermal Growth Factor Receptor Mutation (eGFRm): A Retrospective Cohort Study in a Portuguese Comprehensive Cancer Center
Sep 9, 2025, 16:22 PM -
The DM77 and Rare Diseases: Analysis of Regional Legislation in Italy
Sep 9, 2025, 16:22 PM -
How the EU JCA Could Interface With Regional Pricing Alliances (BeNeLuxA, Nordic Forum, Valletta Group) and EU-Level Procurement Under the Critical Medicines Act
Sep 9, 2025, 16:22 PM -
Empirical Comparison of Four Approaches for Generating Confidence Intervals Around Weighted Trial-Level Correlation
Sep 9, 2025, 16:22 PM -
Price Implications of the Most-Favored Nation Policy on US Oncology Drug Prices
Sep 9, 2025, 16:22 PM -
Understanding the Impact of the NICE Severity Modifier: A Targeted Review of Oncology Submissions
Sep 9, 2025, 16:22 PM -
Utilization of Informal WhatsApp for Pre- and Postnatal Referral Services in the Kwadaso Municipality of Ghana
Sep 9, 2025, 16:22 PM -
Underlying Systemic Motifs That Prevent Diabetes Patients From Seeking and Utilizing Health Services in a Country With a High Prevalence of Diabetes
Sep 9, 2025, 16:22 PM -
Improving Colorectal Cancer Surgical Outcomes Through Audit and Feedback: Results From the Emilia Romagna ESCA Program
Sep 9, 2025, 16:22 PM -
Real-World Evidence on the Broader Benefits of GLP-1RA-Based Therapies: A Global Targeted Literature Review
Sep 9, 2025, 16:22 PM
